Partner at Novo Holdings, Emmanuelle has more than 10 years of venture capital experience. Before joining Novo Holdings, she was a partner at Auriga Partners, specializing in life sciences, and worked at Omnes Capital. She serves on the boards of Draupnir, Minervax, IO Biotech, Heparegenix and Inthera.
Current role